1. Home
  2. DWTX vs COSM Comparison

DWTX vs COSM Comparison

Compare DWTX & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DWTX
  • COSM
  • Stock Information
  • Founded
  • DWTX 2012
  • COSM 2009
  • Country
  • DWTX United States
  • COSM United States
  • Employees
  • DWTX N/A
  • COSM N/A
  • Industry
  • DWTX
  • COSM Other Pharmaceuticals
  • Sector
  • DWTX
  • COSM Health Care
  • Exchange
  • DWTX NYSE
  • COSM Nasdaq
  • Market Cap
  • DWTX 10.1M
  • COSM 8.2M
  • IPO Year
  • DWTX N/A
  • COSM 2013
  • Fundamental
  • Price
  • DWTX $4.89
  • COSM $0.48
  • Analyst Decision
  • DWTX Strong Buy
  • COSM
  • Analyst Count
  • DWTX 1
  • COSM 0
  • Target Price
  • DWTX $10.00
  • COSM N/A
  • AVG Volume (30 Days)
  • DWTX 107.9K
  • COSM 356.0K
  • Earning Date
  • DWTX 05-08-2025
  • COSM 05-15-2025
  • Dividend Yield
  • DWTX N/A
  • COSM N/A
  • EPS Growth
  • DWTX N/A
  • COSM N/A
  • EPS
  • DWTX N/A
  • COSM N/A
  • Revenue
  • DWTX N/A
  • COSM $53,554,457.00
  • Revenue This Year
  • DWTX N/A
  • COSM $28.14
  • Revenue Next Year
  • DWTX N/A
  • COSM N/A
  • P/E Ratio
  • DWTX N/A
  • COSM N/A
  • Revenue Growth
  • DWTX N/A
  • COSM N/A
  • 52 Week Low
  • DWTX $1.62
  • COSM $0.28
  • 52 Week High
  • DWTX $29.28
  • COSM $1.58
  • Technical
  • Relative Strength Index (RSI)
  • DWTX N/A
  • COSM 57.76
  • Support Level
  • DWTX N/A
  • COSM $0.44
  • Resistance Level
  • DWTX N/A
  • COSM $0.50
  • Average True Range (ATR)
  • DWTX 0.00
  • COSM 0.04
  • MACD
  • DWTX 0.00
  • COSM 0.00
  • Stochastic Oscillator
  • DWTX 0.00
  • COSM 75.00

About DWTX DOGWOOD THERAPEUTICS INC

Dogwood Therapeutics Inc, formerly Virios Therapeutics Inc, is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a virus-triggered abnormal immune response, such as fibromyalgia (FM) and long COVID (LC). Its product candidates include IMC-1 and IMC-2. IMC-1 is intended to synergistically suppress herpesvirus activation and replication with a more specific activity against the Epstein-Barr virus (herpesvirus HHV-4, IMC-2 is a combination of valacyclovir and celecoxib.

About COSM Cosmos Health Inc.

Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.

Share on Social Networks: